Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244261 | SCV000306916 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000244261 | SCV000527452 | benign | not specified | 2018-01-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000535392 | SCV000650605 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2P; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000244261 | SCV001879937 | benign | not specified | 2021-01-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003437036 | SCV004147401 | benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | DAG1: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV003437036 | SCV005303491 | benign | not provided | criteria provided, single submitter | not provided |